Steatotic liver disease among lean and non-lean individuals in Southern Lao PDR: a cross-sectional study of risk factors

被引:3
|
作者
Homsana, Anousin [1 ,2 ,3 ]
Southisavath, Phonesavanh [1 ,2 ,3 ,4 ]
Kling, Kerstin [5 ]
Hattendorf, Jan [2 ,3 ]
Vorasane, Savina [4 ]
Paris, Daniel Henry [2 ,3 ]
Sayasone, Somphou [1 ]
Odermatt, Peter [2 ,3 ]
Probst-Hensch, Nicole [2 ,3 ]
机构
[1] Minist Hlth, Lao Trop & Publ Hlth Inst, Vientiane Capital, Laos
[2] Swiss Trop & Publ Hlth Inst, CH-4123 Allschwil, Switzerland
[3] Univ Basel, Basel, Switzerland
[4] Minist Hlth, Dept Radiol, Mahosot Hosp, Vientiane Capital, Laos
[5] Robert Koch Inst, Immunizat Unit, Berlin, Germany
基金
瑞士国家科学基金会;
关键词
Lao PDR; steatotic liver disease; hepatic steatosis; metabolic dysfunction-associated steatotic liver disease; type 2 diabetes mellitus; metabolic diseases; opisthorchis viverrini; lipids; FATTY; DIAGNOSIS;
D O I
10.1080/07853890.2024.2329133
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Steatotic liver disease (SLD) prevalence is rising worldwide, linked to insulin resistance and obesity. SLD prevalence can surpass 10% even among those with normal weight. In Lao People's Democratic Republic (Lao PDR), where Opisthorchis viverrini (OV) trematode infection and type 2 diabetes mellitus (T2DM) are common, infection related liver morbidity such as cholangiocarcinoma (CCA) is high, but data on SLD prevalence is lacking. The objective of this study was to estimate the prevalence and explore determinants of SLD in rural southern Lao PDR for lean and non-lean populations. Method: A cross-sectional community-based study assessed SLD prevalence using abdominal ultrasonography (US). Factors investigated for association with SLD were identified by interview, serological tests (Hepatitis B surface antigen (HBsAg); lipids and HbA1c), anthropometrical measurements, and parasitological assessments (OV infection). Uni- and multivariable logistic regression analyses with SLD as endpoint were conducted separately for lean (body mass index (BMI) <23.0 kg/m(2)) and non-lean (BMI >= 23.0 kg/m(2)) participants. Result: 2,826 participants were included. SLD prevalence was 27.1% (95% confidence interval (95% CI) 24.0%-30.4%), higher among non-lean (39.8%) than lean individuals (17.4%). Lean individuals with OV infection had a statistically significant association with lower odds of SLD (adjusted odds ratio (aOR) 0.49, 95% CI 0.33 - 0.73). T2DM showed a significant positive association with SLD in both lean (aOR 3.58, 95% CI 2.28 - 5.63) and non-lean individuals (aOR 3.31, 95% CI 2.31 - 4.74) while dyslipidemia was significantly associated only in the non-lean group (aOR 1.83, 95% CI 1.09 - 3.07). Females participants exhibited elevated odds of SLD in both lean (aOR 1.43, 95% CI 1.02 - 2.01) and non-lean SLD (aOR 1.50, 95% CI 1.12 - 2.01). Conclusion: SLD prevalence is notably high among Laotian adults in rural areas, particularly in females and in non-lean individuals. Lean individuals with OV infection exhibited lower SLD prevalence. SLD was more prevalent in individuals with T2DM, independent of BMI. SLD adds to the burden of infection-related liver morbidity in Lao PDR.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] PREVALENCE OF CIRRHOSIS AND EXTRAHEPATIC MANIFESTATIONS AMONG LEAN AND NON-LEAN INDIVIDUALS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
    Ghani, Leith K.
    Aboona, Majd B.
    Rangan, Pooja
    Chen, Vincent L.
    Ng, Cheng Han
    Huang, Daniel
    Muthiah, Mark
    Kim, Donghee
    Rubin, Moises I. Nevah
    Han, Ma Ai Thanda
    Fallon, Michael B.
    Wijarnpreecha, Karn
    GASTROENTEROLOGY, 2024, 166 (05) : S1653 - S1654
  • [2] INCIDENCE OF CIRRHOSIS AND EXTRAHEPATIC MANIFESTATIONS AMONG LEAN AND NON-LEAN INDIVIDUALS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
    Aboona, Majd
    Ghani, Leith
    Rangan, Pooja
    Chen, Vincent
    Ng, Cheng Han
    Huang, Daniel
    Muthiah, Mark
    Kim, Donghee
    Rubin, Moises Nevah
    Han, Ma Ai Thanda
    Fallon, Michael
    Wijarnpreecha, Karn
    HEPATOLOGY, 2024, 80 : S852 - S853
  • [3] Natural history of lean and non-lean metabolic dysfunction associated steatotic liver disease
    Wakabayashi, Shun-ichi
    Tamaki, Nobuharu
    Kimura, Takefumi
    Umemura, Takeji
    Kurosaki, Masayuki
    JOURNAL OF HEPATOLOGY, 2024, 80 : S478 - S479
  • [4] Relationship between dietary macronutrient composition and non-alcoholic fatty liver disease in lean and non-lean populations: a cross-sectional study
    Amirkalali, Bahareh
    Khoonsari, Mahmoodreza
    Sohrabi, Masoud Reza
    Ajdarkosh, Hossein
    Motamed, Nima
    Maadi, Mansooreh
    Nobakht, Hossein
    Gholizadeh, Esmaeel
    Zamani, Farhad
    PUBLIC HEALTH NUTRITION, 2021, 24 (18) : 6178 - 6190
  • [5] Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease
    Wakabayashi, Shun-Ichi
    Tamaki, Nobuharu
    Kimura, Takefumi
    Umemura, Takeji
    Kurosaki, Masayuki
    Izumi, Namiki
    JOURNAL OF GASTROENTEROLOGY, 2024, 59 (06) : 494 - 503
  • [6] Prevalence of extrahepatic manifestations in non-alcoholic fatty liver disease in lean individuals compared to non-lean individuals
    Aboona, Majd
    Faulkner, Claire
    Rangan, Pooja
    Chen, Vincent
    Ng, Cheng Han
    Li, Fang
    Wijarnpreecha, Karn
    JOURNAL OF HEPATOLOGY, 2023, 78 : S611 - S611
  • [7] Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations
    Danpanichkul, Pojsakorn
    Suparan, Kanokphong
    Prasitsumrit, Vitchapong
    Ahmed, Aijaz
    Wijarnpreecha, Karn
    Kim, Donghee
    CLINICAL AND MOLECULAR HEPATOLOGY, 2025, 31 (01)
  • [8] Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals
    Aneni, Ehimen C.
    Saeed, Gul Jana
    Bittencourt, Marcio Sommer
    Cainzos-Achirica, Miguel
    Osondu, Chukwuemeka U.
    Budoff, Matthew
    Parise, Edison R.
    Santos, Raul D.
    Nasir, Khurram
    PLOS ONE, 2022, 17 (04):
  • [9] HIGH PREVALENCE OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN LEAN AND NON-LEAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
    Mohamed, Mouhand F.
    Beran, Azizullah
    Chu, Jacqueline J.
    Yang, Wen T.
    Rajadurai, Suvithan
    Ghabril, Marwan S.
    Shah, Samir A.
    Njei, Basile
    GASTROENTEROLOGY, 2024, 166 (05) : S1643 - S1643
  • [10] Predictors of advanced liver fibrosis and the performance of fibrosis scores: lean compared to non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) patients
    Dabbah, Shoham
    Ben Yakov, Gil
    Kaufmann, Monika-Inda
    Cohen-Ezra, Oranit
    Likhter, Maria
    Davidov, Yana
    Ben Ari, Ziv
    MINERVA GASTROENTEROLOGY, 2024, 70 (03): : 322 - 331